Results 171 to 180 of about 10,444 (219)
Some of the next articles are maybe not open access.
Degradation kinetics of mometasone furoate in aqueous systems
International Journal of Pharmaceutics, 2003Mometasone furoate (MF) is a synthetic glucocorticoid. There is little information available on the stability of MF and no degradation products have been unequivocally identified. Thus, the primary objective of this study was to characterize the degradation of MF, qualitatively and quantitatively.
Xiao Wei, Teng +2 more
openaire +2 more sources
METABOLISM OF MOMETASONE FUROATE AND BIOLOGICAL ACTIVITY OF THE METABOLITES
Drug Metabolism and Disposition, 2006To better evaluate the pharmacokinetic and pharmacodynamic properties of the new inhaled glucocorticoid mometasone furoate (MF), the metabolism of MF was evaluated in rat and human tissues and in rat after i.v. administration. Metabolic studies with 3H-MF in human and rat plasma and S9 fractions of human and rat lung showed relatively high stability ...
S, Sahasranaman, M, Issar, G, Hochhaus
openaire +2 more sources
Mometasone Furoate Nasal Spray
Drug Safety, 2007The development of corticosteroids that are delivered directly to the nasal mucosa has alleviated much of the concern about the systemic adverse effects associated with oral corticosteroid therapy. However, given the high potency of these drugs and their widespread use in the treatment of allergic rhinitis, it is important to ensure that intranasal ...
Myron, Zitt +2 more
openaire +2 more sources
Cytokine Inhibition by A Novel Steroid, Mometasone Furoate
Immunopharmacology and Immunotoxicology, 1991Mometasone furoate (9 alpha, 21 dichloro-11 beta, 17 alpha dihydroxy-16 alpha methyl-1,4 pregnadiene-3, 20 dione-17-[2'] furoate) was an unexpectedly potent inhibitor of the in vitro production of three inflammatory cytokines, IL-1(1), IL-6, and TNF-alpha.
B E, Barton +3 more
openaire +2 more sources
Mometasone furoate/formoterol in the treatment of persistent asthma
Expert Review of Respiratory Medicine, 2011Mometasone furoate and formoterol fumarate dihydrate (MF/F) administered via metered-dose inhaler with a dose counter is a new fixed-dose combination of an inhaled corticosteroid and a long-acting β2-agonist indicated for daily maintenance therapy in patients aged ≥12 years with persistent asthma.
openaire +2 more sources
Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates
Case Medical Research, 2020openaire +1 more source